IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 350 filers reported holding IONIS PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 0.40 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $22,000 | +22.2% | 500 | 0.0% | 0.01% | +20.0% |
| Q2 2022 | $18,000 | -10.0% | 500 | -11.2% | 0.01% | 0.0% |
| Q1 2022 | $20,000 | +17.6% | 563 | 0.0% | 0.01% | +25.0% |
| Q4 2021 | $17,000 | +6.2% | 563 | +12.6% | 0.00% | 0.0% |
| Q3 2021 | $16,000 | -15.8% | 500 | 0.0% | 0.00% | -20.0% |
| Q2 2021 | $19,000 | -13.6% | 500 | 0.0% | 0.01% | -16.7% |
| Q1 2021 | $22,000 | -21.4% | 500 | 0.0% | 0.01% | -33.3% |
| Q4 2020 | $28,000 | +21.7% | 500 | 0.0% | 0.01% | +12.5% |
| Q3 2020 | $23,000 | -23.3% | 500 | 0.0% | 0.01% | -27.3% |
| Q2 2020 | $30,000 | +30.4% | 500 | 0.0% | 0.01% | 0.0% |
| Q1 2020 | $23,000 | -23.3% | 500 | 0.0% | 0.01% | +10.0% |
| Q4 2019 | $30,000 | +7.1% | 500 | 0.0% | 0.01% | 0.0% |
| Q3 2019 | $28,000 | -12.5% | 500 | 0.0% | 0.01% | -16.7% |
| Q2 2019 | $32,000 | – | 500 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bellevue Group AG | 9,347,926 | $313,529,000 | 3.18% |
| Sicart Associates LLC | 291,254 | $9,769,000 | 2.66% |
| Camber Capital Management LP | 2,500,000 | $83,850,000 | 2.58% |
| SECTOR GAMMA AS | 263,870 | $8,850,000 | 1.76% |
| Parkman Healthcare Partners LLC | 136,380 | $4,574,000 | 1.16% |
| Eversept Partners, LP | 450,501 | $15,109,804 | 1.05% |
| SPHERA FUNDS MANAGEMENT LTD. | 350,000 | $11,739,000 | 0.99% |
| TANAKA CAPITAL MANAGEMENT INC | 16,661 | $559,000 | 0.80% |
| Sonora Investment Management, LLC | 163,703 | $5,491,000 | 0.69% |
| ARK Investment Management | 8,511,384 | $285,472,000 | 0.69% |